CRISPR Medicine News

CRISPR Medicine News

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.

CLINICAL TRIALS
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Chronic Hepatitis B, HBV, (NCT06680232)
Sponsors:
Precision BioSciences, Inc.
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Read more...Harvard Medical School (@HMS)
Join WDC Chat Community
WDC Chat Community
CRISPR Medicine News
close
Search CRISPR Medicine